Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248781 | 8106888 | F | 8248781-3 | 20110815 | 20120326 | 20120331 | EXP | PHHY2011DE74088 | NOVARTIS PHARMACEUTICAL CORPORATION | YR | F | Y | 20120327 | MD | GERMANY |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248781 | 1019282867 | SS | FEMARA | 1 | ORAL | UNK UKN, UNK | |||||
| 8248781 | 1019282866 | PS | ZOMETA | 1 | INTRACAVERNOUS | UNK UKN, UNK | 021223 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8248781 | 1019282867 | BREAST CANCER |
| 8248781 | 1019282866 | BREAST CANCER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8248781 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 8248781 | EOSINOPHIL COUNT INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8248781 | 1019282867 | 20101201 | |||
| 8248781 | 1019282866 | 20110101 |